Ignite Creation Date:
2024-05-06 @ 6:02 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05523440
Status:
RECRUITING
Last Update Posted:
2024-02-15
First Post:
2022-08-29
Brief Title:
Bevacizumab andor Niraparib in Patients With Recurrent Endometrial andor Ovarian Cancer With ARID1A Mutation
Sponsor:
University of Oklahoma
Organization:
University of Oklahoma
Organization Data
Organization:
University of Oklahoma
Class:
OTHER
Study ID:
OU-SCC-ARID1A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Oklahoma
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |